MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses and Proven U.S. Clinical Trial Supply Experience
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States
MediPharm Labs Provides Operational Update and Increases Average Weekly Production of Active Cannabinoid Component to 75 Million Milligrams
Angkor Resources Announces Further Field Research For Cambodia's Oil And Gas With Mentorship For ITC Graduate Geoscientists
Silverco Mining Announces Key Advisory and Management Appointments to Drive Transition to Mid-Tier Mexican Silver Producer
Gold Runner Exploration Upsizes Non-Brokered Private Placement Financing of Flow-Through Units and Charity Flow Through Units to $3,100,000
